- Prevention in FocusThis article explores why hepatitis C rates are higher among Canadian immigrants and newcomers, including common modes of transmission, and barriers related to testing, and provides recommendations…
- Prevention in FocusCATIE recently endorsed the Consensus Statement of the Prevention Access Campaign, celebrating the fact that “undetectable equals untransmittable.” This revolutionary statement, pushed forward by a…
- An American demonstration project has shown that young gay, bisexual and other men who have sex with men (MSM) who have sex that may expose them to HIV in an ongoing way find the care and support…
- A study has shown that 95% of participants in a rapid HIV treatment initiation program start antiretroviral treatment (ART) within 24 hours of being diagnosed with HIV.
- The fixed-dose combination of sofosbuvir + velpatasvir (sold as Epclusa) has activity against all major strains, or genotypes, of hepatitis C virus (HCV). The ...
- Researchers conducted a double-blind placebo-controlled study of the combination of sofosbuvir + velpatasvir (Epclusa) in participants with hepatitis C virus ...
- CATIE NewsA ccording to the Centers for Disease Control and Prevention (CDC), in the past two years there have been more than 200 reported cases of syphilis affecting the ...
- CATIE NewsStudies have found that some people who do not have access to primary healthcare may resort to using the Emergency Room (ER) of their local hospital for care ...
- Positive SideThank you - your subscription to The Positive Side has been ...
- CATIE NewsPeople who have been sexually exposed to HIV who initiate anti-HIV therapy within 72 hours of such an exposure and who continue to take these medicines every ...
- CATIE NewsThe widespread availability of potent anti-HIV therapy (commonly called ART) in Canada and other high-income countries has had a tremendous impact on the health ...